The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 Diabetes
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01404676 |
Recruitment Status
: Unknown
Verified July 2011 by Samsung Medical Center.
Recruitment status was: Recruiting
First Posted
: July 28, 2011
Last Update Posted
: July 28, 2011
|
Sponsor:
Samsung Medical Center
Information provided by:
Samsung Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Unknown |
---|---|
Estimated Primary Completion Date : | May 2012 |
Estimated Study Completion Date : | May 2012 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):